IMI PLC Reports 5% Organic Profit Growth and Confirms Full-Year Guidance

Right then, let’s unpack IMI PLC’s latest interim results. The headline figures tell a story of resilience and strategic execution, even amidst a few bumps in the road. For a company deeply embedded in mission-critical fluid and motion control across vital sectors like automation, life sciences, and climate tech, delivering 5% organic operating profit growth isn’t just a number – it’s validation of their ‘One IMI’ operating model.

Cutting Through The Headline Numbers

IMI’s core performance metrics demonstrate underlying strength, even if statutory figures look softer due to external factors:

• Organic Revenue Growth: +2% (H1 2025 vs H1 2024). This marks progress towards the anticipated fourth consecutive year of mid-single-digit growth.
• Organic Adjusted Operating Profit Growth: +5%. This is the golden nugget – translating top-line growth efficiently into profit.
• Adjusted Operating Margin: Increased 30 basis points to 18.2%. Efficiency gains and a focus on higher-margin aftermarket sales (now ~45% of group revenue) are paying dividends.
• Statutory Reality Check: Revenue dipped 1% (£1,091m vs £1,098m), and statutory operating profit fell 10%, largely due to foreign exchange headwinds and the significant, one-off £25m cost from the Q1 cyber incident.
• Dividend Hike: Proposed interim dividend up 10% to 11.0p per share. A clear signal of confidence.
• Capital Return: Completed a £200m share buyback in July, bringing total shareholder returns since 2019 over £1 billion.
• Balance Sheet: Net debt/adjusted EBITDA at 1.4x, sitting comfortably within the target range (1x-2x).

Where The Growth Came From (And Where It Was Tempered)

The story diverges across IMI’s two main platforms:

1. Automation: Process Shines, Industrial Rebounds

• Process Automation (The Star): Organic revenue surged 8%. Crucially, aftermarket orders jumped 10% organically – the high-margin, recurring revenue dream. Excluding a chunky one-off marine order last year, total orders were up 7%. The order book is 5% higher than June 2024. Power and Nuclear were standout sectors.
• Industrial Automation (Recovering): Organic revenue down 4%. This was expected and directly linked to the Q1 cyber disruption and softer industrial demand in Europe/Americas. The key takeaway? Management states momentum is rebuilding, and the order book looks supportive for H2.
• Automation Overall: Organic revenue +3%, adjusted operating margin stable at 18.4%.

2. Life Technology: Mixed Bag, But H2 Promise

• Climate Control (Strong): Organic revenue up 5%. Demand for energy-saving solutions in buildings remains robust, boosted by smart, connected products.
• Life Science & Fluid Control (Softer): Organic revenue down 5%. Life Science sales were only slightly down, but Fluid Control took a hit from the cyber incident. Encouragingly, the order book is strong for H2 recovery.
• Transport (Expected Dip): Organic revenue down 9%. This was flagged, coming off a very strong H1 2024 (13% growth). Order book supportive for H2.
• Life Technology Overall: Organic revenue down 1%, BUT adjusted operating profit up 4% organically and margin improved significantly by 80bps to 17.8%. That’s operational leverage in action.

The Cyber Incident: A Costly Hiccup, But Contained

Let’s address the elephant in the room. The February cyber attack resulted in a £25m adjusting item hit in H1, covering recovery, risk management, infrastructure upgrades, and advisory costs. This materially impacted the statutory figures, particularly for Industrial Automation and Fluid Control. The positive spin? The company reacted swiftly, contained the threat, and crucially, states operations are now rebuilding momentum. It’s a reminder of operational risk, but not a long-term strategic setback.

Capital Allocation: Walking The Talk

IMI isn’t just generating profit; it’s deploying capital with discipline and shareholder focus:

• Progressive Dividend: The 10% interim hike speaks volumes.
• Aggressive Buybacks: £200m completed in July. This follows significant returns since 2019.
• Investment Capacity: Net debt at 1.4x EBITDA provides ample headroom. The priority remains funding organic growth and value-accretive bolt-on M&A (with a strong pipeline noted, particularly in US/Europe).
• Free Cash Flow: Reported FCF was lower (£30m vs £65m H1 2024), but this was heavily impacted by the cyber costs and a £26m loan to the UK pension scheme (expected to be partially repaid H2). Underlying cash generation remains solid.

Outlook: Confidence Rings Loud And Clear

CEO Roy Twite was unequivocal: “I am therefore very pleased to reconfirm our guidance for 2025.” The pillars supporting this confidence are robust:

1. Sector Momentum: Record Process Automation order book, strong Climate Control demand, Industrial Automation recovery, and supportive order books in Transport & Life Science/Fluid Control.
2. Strategic Model: The ‘One IMI’ operating model, driving commercial excellence, market-led innovation (Growth Hub orders up 23%!), and continuous improvement.
3. Guidance Reaffirmed:
   • Fourth consecutive year of mid-single-digit organic revenue growth on track.
   • Full-year adjusted basic EPS expected between 129p – 136p.

They do note headwinds: FX translation is now expected to be a ~1.5% drag on adjusted operating profit for the full year, and interest expense will rise slightly (£19m-£20m) due to funding the buyback.

The Investor Takeaway: Compounding In Action

IMI’s H1 results paint a picture of a company executing a well-defined strategy with discipline. The 5% organic profit growth, achieved despite a significant one-off cost, underscores the resilience of their model and their leading positions in structurally growing markets. The commitment to returning capital (dividend hike, buybacks) is shareholder-friendly, while maintaining balance sheet strength for organic and inorganic growth.

The cyber incident was a costly operational setback, but the recovery appears well-managed. With strong momentum heading into H2 across key sectors and full-year guidance confidently reiterated, IMI seems positioned to continue its track record of compounding growth. For investors seeking industrial exposure with pricing power, recurring revenue streams (aftermarket), and disciplined capital allocation, IMI warrants close attention. The transformation since 2019 continues to deliver.